Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06792175 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial
NCT06792175 · ClinicalTrials.gov record · last posted 2025-09-03

Mental Health, Intellectual and Neurodevelopmental Disorder Detection With Artificial Intelligence Models

Study acronym: MINDAIM
StatusEnrolling by Invitation
PhaseNot specified
Started2025-02-04
View on ClinicalTrials.gov ↗
Record status
This record was last updated September 3, 2025 (before its estimated February 2026 completion). Its status may not reflect the trial's current state.
from the ClinicalTrials.gov record
This study investigates whether AI-driven analysis of speech can accurately predict clinical diagnoses and assess risk for various mental or behavioral health conditions, including attention-deficit/hyperactivity disorder (ADHD), autism spectrum disorder, bipolar disorder, generalized anxiety disorder, major depressive disorder, obsessive compulsive disorder (OCD), post-traumatic stress disorder (PTSD), and schizophrenia. We aim to develop tools that can support clinicians in making more accurate and efficient diagnoses.

Amendment record 2 amendments on the ClinicalTrials.gov record

This ClinicalTrials.gov record has been amended 2 times since 2025-01-19; most recent amendment 2025-08-26. DataLookout shows field-level changes from the day a trial enters its daily monitoring; earlier amendments are counted here from the ClinicalTrials.gov version history. See every version on ClinicalTrials.gov ↗

2025-02-09
Status change Not Yet Recruiting→Enrolling by Invitationv1
Trial Details
NCT Number NCT06792175
Lead Sponsor Psyrin Inc.
Collaborators: Allwell Behavioral Health Services, The Brookline Center
Conditions Autism Spectrum Disorder, Depression - Major Depressive Disorder, Anxiety, Generalized, Bipolar Disorder (BD), Attention Deficit Hyperactivity Disorder (ADHD), Schizophrenia Spectrum & Other Psychotic Disorders, Post Traumatic Stress Disorder, Obsessive Compulsive Disorder (OCD)
Enrollment 500 participants
Start Date 2025-02-04
Primary Completion 2026-02 (estimated)
Study Completion 2026-07 (estimated)
Updated on ClinicalTrials.gov 2025-09-03